Loading...
| A03248 | Pages: NA | Aug 2021 | 3922 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Corneal Pachymetry Market
Request Now !Corneal pachymetry is a procedure of determining the thickness of eyes cornea using a medical device known as pachymeter. Corneal pachymetry can be carried out either by ultrasonic or optical methods. In corneal pachymetry, pachymeter using ultrasonic transducer which touches the cornea and measures the thickness of the cornea, usually in micrometres.
Increase in incidence of eye disorders such as glaucoma, growth in geriatric population, and rise in patients concerns regarding eye disorders through education drive the market. Moreover, technological advancements in handheld devices for detecting glaucoma and advancement in R&D activities further enhance the market growth. However, high cost of devices and stringent regulatory compliance norms majorly hamper the market growth. Increase in eye disorders such as glaucoma and diabetic retinopathy, and development of novel devices by key vendors and their approvals provide numerous opportunities in near future.
The corneal pachymetry market is segmented on the basis of type, application, end user, and region. Based on type, the market is divided into ultrasonic method, and optical method. Based on application, it is bifurcated into glaucoma diagnosis and refractive surgery.
On the basis of end user, the market is classified into hospitals, clinics, and others. By geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in this market include DGH Technology, Inc., Tomey Corporation, MicroMedical Devices, Inc., NIDEK CO., LTD., Accutome Inc., Oculus VR, Sonomed Escalon, Konan Medical USA, Inc., Optovue, Incorporated, and MEDA Co., Ltd.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 CORNEAL PACHYMETRY MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. ULTRASONIC METHOD
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. OPTICAL METHOD
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
CHAPTER 5 CORNEAL PACHYMETRY MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. GLAUCOMA DIAGNOSIS
5.2.1. Market size and forecast
5.3. REFRACTIVE SURGERY
5.3.1. Market size and forecast
CHAPTER 6 CORNEAL PACHYMETRY MARKET, BY END USER
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. HOSPITALS
6.2.1. Market size and forecast
6.3. CLINICS
6.3.1. Market size and forecast
6.4. OTHERS
6.4.1. Market size and forecast
CHAPTER 7 CORNEAL PACHYMETRY MARKET, BY REGION
7.1. OVERVIEW
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast
7.2.4. North America Corneal Pachymetry Market by Type
7.2.5. North America Corneal Pachymetry Market by Application
7.2.6. North America Corneal Pachymetry Market by End User
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast
7.3.4. Europe Corneal Pachymetry Market by Type
7.3.5. Europe Corneal Pachymetry Market by Application
7.3.6. Europe Corneal Pachymetry Market by End User
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. South Korea market size and forecast
7.4.3.6. Rest of Asia-Pacific market size and forecast
7.4.4. Asia-Pacific Corneal Pachymetry Market by Type
7.4.5. Asia-Pacific Corneal Pachymetry Market by Application
7.4.6. Asia-Pacific Corneal Pachymetry Market by End User
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.3.1. Brazil market size and forecast
7.5.3.2. Saudi Arabia market size and forecast
7.5.3.3. South Africa market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast
7.5.4. LAMEA Corneal Pachymetry Market by Type
7.5.5. LAMEA Corneal Pachymetry Market by Application
7.5.6. LAMEA Corneal Pachymetry Market by End User
CHAPTER 8 COMPANY PROFILES
8.1. DGH TECHNOLOGY, INC.
8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments
8.2. TOMEY CORPORATION
8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments
8.3. MICROMEDICAL DEVICES, INC.
8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments
8.4. NIDEK CO., LTD.
8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments
8.5. ACCUTOME INC.
8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments
8.6. OCULUS VR
8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments
8.7. SONOMED ESCALON
8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments
8.8. KONAN MEDICAL USA, INC.
8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments
8.9. OPTOVUE, INCORPORATED
8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments
8.10. MEDA CO., LTD.
8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
